ClinicalTrials.Veeva

Menu
H

Hospital das Clinicas da Universidade Federal de Goias | Centro de Pesquisa em Cardiologia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tolvaptan
Blinatumomab
Treprostinil
Olpasiran
Milvexian
Ixazomib
UT-15C

Parent organization

This site is a part of Hospital das Clinicas da Universidade Federal de Goias

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 9 total trials

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling
Acute Coronary Syndrome
Drug: Milvexian
Other: Placebo

The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (C...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo

The safety run-in part of the study aims to evaluate the safety and tolerability of blinatumomab alternating with low-intensity chemotherapy. The pha...

Enrolling
Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
Drug: Low-intensity chemotherapy regimen
Drug: Blinatumomab

Trial sponsors

Amgen logo
Takeda logo
United Therapeutics logo
Janssen (J&J Innovative Medicine) logo
Otsuka logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems